PharmaShots | Incisive News in 3 Shots

Subscribe Now

Innocure

Innocare Announces the Results of P-II Study for TYK2 Inhibitor ICP-332 in Patients with Atopic Dermatitis

Innocare Announces the Results of P-II Study for TYK2 Inhibitor ICP-332 in Patients with Atopic Dermatitis

December 18, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us